tiprankstipranks
Trending News
More News >
TransCode Therapeutics (RNAZ)
NASDAQ:RNAZ
US Market

TransCode Therapeutics (RNAZ) Technical Analysis

Compare
436 Followers

Technical Sentiment

Overall Consensus
Neutral
11Bullish
2Neutral
9Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
TransCode Therapeutics’s (RNAZ) Moving Averages Convergence Divergence (MACD) indicator is -0.13, suggesting TransCode Therapeutics is a Sell.
TransCode Therapeutics’s (RNAZ) 20-Day exponential moving average is 7.98, while TransCode Therapeutics’s (RNAZ) share price is $6.96, making it a Buy.
TransCode Therapeutics’s (RNAZ) 50-Day exponential moving average is 8.75, while TransCode Therapeutics’s (RNAZ) share price is $6.96, making it a Buy.

TransCode Therapeutics (RNAZ) Pivot Points

Jan 16, 2026, 04:30 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
7.11
7.41
7.98
8.28
8.85
9.15
9.72
Fibonacci
7.41
7.75
7.95
8.28
8.62
8.82
9.15
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

TransCode Therapeutics (RNAZ) Moving Averages

Jan 16, 2026, 04:30 AM
Period
Simple
Exponential
MA5
8.29Buy
8.36Buy
MA10
7.78Buy
8.02Buy
MA20
7.68Buy
7.98Buy
MA50
8.53Buy
8.75Buy
MA100
10.13Sell
12.56Sell
MA200
9.90Sell
28.70Sell
TransCode Therapeutics’s (RNAZ) 10-Day exponential moving average is 8.02, while TransCode Therapeutics’s (RNAZ) share price is $6.96, making it a Buy.
TransCode Therapeutics’s (RNAZ) 100-Day exponential moving average is 12.56, while TransCode Therapeutics’s (RNAZ) share price is $6.96, making it a Sell.
TransCode Therapeutics’s (RNAZ) stock price is $6.96 and TransCode Therapeutics’s (RNAZ) 50-day simple moving average is 8.53, creating a Buy signal.
TransCode Therapeutics’s (RNAZ) stock price is $6.96 and TransCode Therapeutics’s (RNAZ) 100-day simple moving average is 10.13, creating a Sell signal.
TransCode Therapeutics’s (RNAZ) stock price is $6.96 and TransCode Therapeutics’s (RNAZ) 200-day simple moving average is 9.90, creating a Sell signal.

TransCode Therapeutics (RNAZ) Technical Indicators

Jan 16, 2026, 04:30 AM
Name
Value
Implied Action
RSI (14)
60.79
Neutral
STOCH (9,6)
91.80
Sell
STOCHRSI (14)
90.00
Sell
MACD (12,26)
-0.13
Sell
ADX (14)
19.93
Buy
Williams %R
-7.55
Sell
CCI (14)
132.78
Sell
ATR (14)
0.84
-
Ultimate Oscillator
65.14
Neutral
ROC
19.79
Buy
TransCode Therapeutics’s (RNAZ) Relative Strength Index (RSI) is 60.79, creating a Neutral signal.
TransCode Therapeutics’s (RNAZ) Trend Strength Indicator (ADX) is 19.93, creating a Buy signal.
TransCode Therapeutics’s (RNAZ) Commodity Channel Index (CCI) is 132.78, creating a Sell signal.
TransCode Therapeutics’s (RNAZ) Price Rate of Change (ROC) is 19.79, creating a Buy signal.

FAQ

Is RNAZ a Buy, Hold, or Sell?
Based on RNAZ’s technical indicators, RNAZ is a Hold.
    What is RNAZ’s RSI (14)?
    RNAZ’s RSI (14) is 60.79, which suggests RNAZ is a Neutral.
      What is RNAZ’s MACD?
      RNAZ’s MACD is -0.13, which suggests RNAZ is a Sell.
        What is RNAZ’s 5-day moving average?
        RNAZ’s 5-day moving average is 8.29, which suggests RNAZ is a Buy.
          What is RNAZ’s 20-day moving average?
          RNAZ 20-day moving average is 7.68, which suggests RNAZ is a Buy.
            What is RNAZ’s 50-day moving average?
            RNAZ’s 50-day moving average is 8.53, which suggests RNAZ is a Buy.
              What is RNAZ’s 200-day moving average?
              RNAZ’s 200-day moving average is 9.90, which suggests RNAZ is a Sell.
                What is RNAZ’s Williams % R (14)?
                RNAZ’s Williams % R (14) is -7.55, which suggests RNAZ is a Sell.
                  What is RNAZ’s CCI (14)?
                  RNAZ’s CCI (14) is 132.78, which suggests RNAZ is a Sell.